Business Standard

US FDA authorises two Covid boosters targeted at Omicron subvariants

US approves Omicron vaccines from Moderna and BioNTech/Pfizer

Moderna vaccine
Premium

Photo: Shutterstock

Reuters
The US Food and Drug Administration on Wednesday authorised updated COVID-19 booster shots from Pfizer /BioNTech and Moderna that target the dominant BA.4 and BA.5 Omicron subvariants, as the government prepares for a fall vaccination campaign that could begin in a few days.

Both vaccines also include the original version of the virus targeted by all the previous COVID shots.

The FDA authorized the shots for everyone over aged 12 who has had a primary vaccination series and is at least two months out from a previous booster shot, shorter than prior recommended intervals. That marks a shift from the current shots

Disclaimer: No Business Standard Journalist was involved in creation of this content

Topics : Coronavirus

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Aug 31 2022 | 10:43 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com